70 results
Page 3 of 4
8-K
n7v7axu9tzsmbxd1
9 Sep 20
Departure of Directors or Certain Officers
8:02am
8-K
EX-10.1
jguoje wv
9 Sep 20
Departure of Directors or Certain Officers
8:02am
8-K
EX-99.1
5v1vwtq9v bvc9shlx
10 Aug 20
UroGen Pharma Reports Second Quarter 2020 Financial Results and Recent Corporate Developments
7:20am
8-K
EX-10.1
kq3h7uad4539
23 Mar 20
Departure of Directors or Certain Officers
7:31am
S-3
EX-4.2
kuczzmcrqs7fdi
20 Dec 19
Shelf registration
4:17pm
8-K
EX-99.3
p4yw 8vfx3xmx5lsrm0x
24 Sep 19
Durability of Response Determined to be 89 Percent at Six Months and 84 Percent at 12 Months
5:20pm
8-K
EX-99.2
i5f9scffbh1upki mvs
24 Sep 19
Durability of Response Determined to be 89 Percent at Six Months and 84 Percent at 12 Months
5:20pm
10-Q
2je2d
9 May 19
Quarterly report
7:13am
DEF 14A
ll8njtes
26 Apr 19
Definitive proxy
5:00pm
10-K
EX-10.11
in621gp9b5
28 Feb 19
Annual report
1:08pm
10-K
EX-10.13
1ailswg
28 Feb 19
Annual report
1:08pm
10-K
EX-10.14
3u1vf1xp9a5g4 adwp
28 Feb 19
Annual report
1:08pm